0.30 USD
▲+0.03+1.00%
盘后 0.31 +1.33%
2026-08-03
市值
$17.22M
市盈率
—
EPS
-2.37
股息率
—
52 周区间
0.25 – 3.05
成交量
1.42M
Beta
-0.40
目标价
4.50
52W 低 0.2552W 高 3.05
价格走势
公司简介
Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was inco...